bisoprolol has been researched along with Postural Orthostatic Tachycardia Syndrome in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Postural Orthostatic Tachycardia Syndrome: A syndrome of ORTHOSTATIC INTOLERANCE combined with excessive upright TACHYCARDIA, and usually without associated ORTHOSTATIC HYPOTENSION. All variants have in common an excessively reduced venous return to the heart (central HYPOVOLEMIA) while upright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, J | 1 |
| Kim, DY | 1 |
| Lee, WJ | 1 |
| Lee, HS | 1 |
| Lim, JA | 1 |
| Kim, TJ | 1 |
| Jun, JS | 1 |
| Park, B | 1 |
| Byun, JI | 1 |
| Sunwoo, JS | 1 |
| Lee, ST | 1 |
| Jung, KH | 1 |
| Park, KI | 1 |
| Jung, KY | 1 |
| Kim, M | 1 |
| Lee, SK | 1 |
| Chu, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Effect of Propranolol, Bisoprolol, Pyridosgitmine in Postural Orthostatic Tachycardia Syndrome (POTS) and Prognosis After Medical Treatment[NCT02171988] | Phase 4 | 150 participants (Actual) | Interventional | 2014-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for bisoprolol and Postural Orthostatic Tachycardia Syndrome
| Article | Year |
|---|---|
Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Bisoprolol; Female; Foll | 2018 |